Traditional Chinese medicine composition as well as preparation method and application thereof
By combining traditional Chinese medicines such as cinnamon twig, poria cocos, peony bark, peach kernel, white peony root, dipsacus root, processed epimedium, and sparganium rhizome, and preparing granules and other dosage forms, the problem of unclear effects of existing traditional Chinese medicines in treating bladder outlet obstruction has been solved. This has achieved significant reduction in prostate index and sex hormone levels, and improved the therapeutic effect of bladder outlet obstruction.
Patent Information
- Application Number
- CN202411737080.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-11-29
- Publication Date
- 2026-05-29
AI Technical Summary
The existing Chinese medicine drugs have unclear mechanisms of action in treating benign prostatic hyperplasia (BPH), making them difficult to effectively target prostatic hyperplasia caused by multiple etiologies. Furthermore, minimally invasive surgery and Western medicine treatments carry the risk of complications.
A traditional Chinese medicine composition is provided, consisting of cinnamon twig, poria cocos, peony bark, peach kernel, white peony root, dipsacus root, processed epimedium, and sparganium rhizome. It is prepared into dosage forms such as granules and capsules through compounding and extraction, and is used to treat benign prostatic hyperplasia, with synergistic therapeutic effects.
This traditional Chinese medicine composition significantly reduces the prostate index in model mice and rats, alleviates interstitial edema, lowers serum sex hormone levels, and improves bladder outlet obstruction and prostatic hyperplasia. It has a significant therapeutic effect on benign prostatic hyperplasia and is superior to the use of Guizhi Fuling capsules alone or the combination of Chuanduan + Zhiyinyanghuo + Sanleng.